| Year |
Citation |
Score |
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Modugno F, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.438 |
|
| 2024 |
Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching PA, Lambrechts D, García MJ, Rodríguez-Antona C, Goodman MT, Modugno F, Moysich KB, Karlan BY, Lester J, et al. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. Npj Genomic Medicine. 9: 19. PMID 38443389 DOI: 10.1038/s41525-024-00395-y |
0.317 |
|
| 2023 |
Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, et al. A framework for assessing interactions for risk stratification models: the example of ovarian cancer. Journal of the National Cancer Institute. PMID 37436712 DOI: 10.1093/jnci/djad137 |
0.405 |
|
| 2023 |
May T, Bernardini M, Lheureux S, Aben KKH, Bandera EV, Beckmann MW, Benitez J, Berchuck A, Bjørge L, Carney ME, Cramer DW, deFazio A, Dörk T, Eccles DM, Friedlander M, ... ... Modugno F, et al. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 66: E310-E320. PMID 37369443 DOI: 10.1503/cjs.017020 |
0.315 |
|
| 2023 |
Gersekowski K, Ibiebele TI, Doherty JA, Harris HR, Goodman MT, Terry KL, Wu AH, Bandera EV, Qin B, Ong JS, Tyrer JP, Dixon-Suen SC, Modugno F, Risch HA, Webb PM. Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 37220873 DOI: 10.1158/1055-9965.EPI-23-0121 |
0.49 |
|
| 2023 |
Hurwitz LM, Webb PM, Jordan SJ, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Schildkraut JM, Berchuck A, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, et al. Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. Jama Network Open. 6: e230666. PMID 36826816 DOI: 10.1001/jamanetworkopen.2023.0666 |
0.451 |
|
| 2023 |
Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Brooks-Wilson A, Chang-Claude J, Cook LS, Cramer DW, Cushing-Haugen KL, Doherty JA, ... ... Modugno F, et al. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. Journal of the National Cancer Institute. PMID 36688720 DOI: 10.1093/jnci/djad011 |
0.436 |
|
| 2022 |
Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DDL, Fasching PA, Goode EL, Goodman MT, Karlan BY, Lester J, Matsuo K, Modugno F, Brenton JD, Van Gorp T, et al. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecologic Oncology. 168: 68-75. PMID 36401943 DOI: 10.1016/j.ygyno.2022.10.018 |
0.324 |
|
| 2022 |
DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, ... ... Modugno F, et al. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute. PMID 36210504 DOI: 10.1093/jnci/djac160 |
0.378 |
|
| 2022 |
Phung MT, Muthukumar A, Trabert B, Webb PM, Jordan SJ, Terry KL, Cramer DW, Titus LJ, Risch HA, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich KB, Jensen A, et al. Effects of risk factors for ovarian cancer in women with and without endometriosis. Fertility and Sterility. PMID 36182623 DOI: 10.1016/j.fertnstert.2022.07.019 |
0.47 |
|
| 2022 |
Hurwitz LM, Townsend MK, Jordan SJ, Patel AV, Teras LR, Lacey JV, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Robien K, Prizment A, Schildkraut JM, et al. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101900. PMID 35867953 DOI: 10.1200/JCO.21.01900 |
0.489 |
|
| 2022 |
Fu Z, Taylor S, Modugno F. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis. Gynecologic Oncology. 165: 650-663. PMID 35473671 DOI: 10.1016/j.ygyno.2022.04.001 |
0.415 |
|
| 2022 |
Wohlmuth C, Djedovic V, Kjaer SK, Jensen A, Glasspool R, Roxburgh P, DeFazio A, Johnatty SE, Webb PM, Modugno F, Lambrechts D, Schildkraut JM, Berchuck A, Thomsen LCV, Bjorge L, et al. CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis. Cancers. 14. PMID 35454861 DOI: 10.3390/cancers14081954 |
0.319 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Modugno F, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35314806 DOI: 10.1038/s41431-022-01085-y |
0.355 |
|
| 2022 |
Lemon LS, Orr B, Modugno F, Buckanovich RJ, Coffman L, Edwards RP, Taylor S. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer? Gynecologic Oncology. PMID 35140015 DOI: 10.1016/j.ygyno.2022.01.022 |
0.412 |
|
| 2022 |
Phung MT, Alimujiang A, Berchuck A, Anton-Cluver H, Schildkraut JM, Bandera EV, Chang-Claude J, Chase A, Doherty JA, Grout B, Goodman MT, Hanley GE, Lee AW, McKinnon Deurloo C, Menon U, ... Modugno F, et al. Reproductive factors do not influence survival with ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35064059 DOI: 10.1158/1055-9965.EPI-21-1091 |
0.45 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Modugno F, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.428 |
|
| 2021 |
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, ... ... Modugno F, et al. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789471 DOI: 10.1158/1055-9965.EPI-21-0977 |
0.428 |
|
| 2021 |
Khoja L, Weber RP, Webb PM, Jordan SJ, Muthukumar A, Chang-Claude J, Fortner RT, Jensen A, Kjaer SK, Risch H, Doherty JA, Harris HR, Goodman MT, Modugno F, et al. Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecologic Oncology. PMID 34776242 DOI: 10.1016/j.ygyno.2021.10.088 |
0.349 |
|
| 2021 |
Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, Glubb DM, Tyrer JP, Armasu SM, Ong JS, Gharahkhani P, Lu Y, Gao B, Patch AM, ... ... Modugno F, et al. Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34162658 DOI: 10.1158/1055-9965.EPI-20-1817 |
0.399 |
|
| 2021 |
Phung MT, Lee AW, Wu AH, Berchuck A, Cho KR, Cramer DW, Doherty JA, Goodman MT, Hanley GE, Harris HR, McLean K, Modugno F, Moysich KB, Mukherjee B, Schildkraut JM, et al. Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33619020 DOI: 10.1158/1055-9965.EPI-20-1355 |
0.501 |
|
| 2021 |
Fu Z, Kelley JL, Odunsi K, Edwards RP, Moysich K, Modugno F. Gestational weight gain and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. PMID 33616777 DOI: 10.1007/s10552-021-01405-5 |
0.451 |
|
| 2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Modugno F, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.475 |
|
| 2020 |
Modugno F, Fu Z, Jordan SJ, Group A, Chang-Claude J, Fortner RT, Goodman MT, Moysich KB, Schildkraut JM, Berchuck A, Bandera EV, Qin B, Sutphen R, McLaughlin JR, Menon U, et al. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies. European Journal of Epidemiology. PMID 32959149 DOI: 10.1007/S10654-020-00682-9 |
0.47 |
|
| 2020 |
Stenzel AE, Abrams SI, Joseph JM, Goode EL, Tario JD, Wallace PK, Kaur D, Adamson AK, Buas MF, Lugade AA, Laslavic A, Taylor SE, Orr B, Edwards RP, Elishaev E, ... ... Modugno F, et al. Circulating CD14 HLA-DR monocytic cells as a biomarker for epithelial ovarian cancer progression. American Journal of Reproductive Immunology (New York, N.Y. : 1989). e13343. PMID 32905653 DOI: 10.1111/Aji.13343 |
0.407 |
|
| 2020 |
Heayn M, Skvarca LB, Zhu L, Edwards RP, Olawaiye AB, Modugno F, Elishaev E, Bhargava R. Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant Chemotherapy. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 32897953 DOI: 10.1097/Pgp.0000000000000706 |
0.342 |
|
| 2020 |
Lee AW, Rosenzweig S, Wiensch A, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, ... ... Modugno F, et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. Journal of the National Cancer Institute. PMID 32766851 DOI: 10.1093/Jnci/Djaa099 |
0.548 |
|
| 2020 |
Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, ... ... Modugno F, et al. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecologic Oncology. PMID 32641237 DOI: 10.1016/J.Ygyno.2020.06.481 |
0.46 |
|
| 2020 |
Martins FC, Couturier DL, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Gentry-Maharaj A, Vrvilo A, Hein A, Talhouk A, Osorio A, Hartkopf AD, Brooks-Wilson A, DeFazio A, ... ... Modugno F, et al. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer. PMID 32555365 DOI: 10.1038/S41416-020-0900-0 |
0.497 |
|
| 2020 |
Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, ... ... Modugno F, et al. Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics. PMID 32546565 DOI: 10.1136/Jmedgenet-2019-106739 |
0.478 |
|
| 2020 |
Brown JR, Chan DK, Shank JJ, Griffith KA, Fan H, Szulawski R, Yang K, Reynolds RK, Johnston C, McLean K, Uppal S, Liu JR, Cabrera L, Taylor SE, Orr BC, ... Modugno F, et al. Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer. Jci Insight. PMID 32369446 DOI: 10.1172/Jci.Insight.133247 |
0.4 |
|
| 2020 |
Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, Harris HR, Rossing MA, Doherty JA, Fortner RT, Chang-Claude J, Goodman MT, Thompson PJ, Moysich KB, Ness RB, ... ... Modugno F, et al. Association Between Breastfeeding and Ovarian Cancer Risk. Jama Oncology. e200421. PMID 32239218 DOI: 10.1001/Jamaoncol.2020.0421 |
0.538 |
|
| 2020 |
Lee AW, Wu AH, Wiensch A, Mukherjee B, Terry KL, Harris HR, Carney ME, Jensen A, Cramer DW, Berchuck A, Doherty JA, Modugno F, Goodman MT, Alimujiang A, Rossing MA, et al. Estrogen plus progestin hormone therapy and ovarian cancer: a complicated relationship explored. Epidemiology (Cambridge, Mass.). PMID 32028322 DOI: 10.1097/Ede.0000000000001175 |
0.475 |
|
| 2020 |
Heng YJ, Hankinson SE, Wang J, Alexandrov LB, Ambrosone CB, Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, Eliassen AH, Tamimi RM, Kraft P. The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: The Cancer Genome Atlas Network. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31932411 DOI: 10.1158/1055-9965.Epi-19-1087 |
0.467 |
|
| 2020 |
Phung MT, Webb PM, Doherty JA, Harris HR, Thompson PJ, Goodman MT, Moysich K, Modugno F, Ness RB, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Titus L, Lee AW, et al. Abstract B38: Use of progestin-only injectable contraceptive is associated with reduced risk of ovarian cancer in the Ovarian Cancer Association Consortium Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-B38 |
0.576 |
|
| 2020 |
Heng YJ, Hankinson SE, Wang J, Alexandrov LB, Ambrosone CB, Andrade VPd, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, Eliassen AH, Tamimi RM, Kraft P. Abstract P5-08-07: Tobacco use, alcohol consumption, and breast cancer somatic genomic alterations Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-08-07 |
0.477 |
|
| 2020 |
Phung MT, Mukherjee B, Lee AW, Webb PM, Risch HA, Doherty JA, Harris HR, Goodman MT, Ness RB, Modugno F, Jensen A, Kjaer SK, Terry KL, Cramer DW, Ziogas A, et al. Abstract 3498: Ovarian cancer risk factors multiply to create high risk in pre-menopausal women Epidemiology. DOI: 10.1158/1538-7445.Am2020-3498 |
0.493 |
|
| 2019 |
Fu Z, Moysich K, Ness RB, Modugno F. Gender of offspring and risk of ovarian cancer: The HOPE study. Cancer Epidemiology. 64: 101646. PMID 31835157 DOI: 10.1016/J.Canep.2019.101646 |
0.559 |
|
| 2019 |
Gutkin DW, Shurin MR, El Azher MA, Shurin GV, Velikokhatnaya L, Prosser D, Shin N, Modugno F, Stemmer P, Elishaev E, Lokshin A. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomarkers : Section a of Disease Markers. PMID 31658047 DOI: 10.3233/Cbm-190528 |
0.363 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Modugno F, et al. Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 4386. PMID 31548585 DOI: 10.1038/S41467-019-12095-8 |
0.381 |
|
| 2019 |
Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, ... ... Modugno F, et al. Identification of novel epithelial ovarian cancer loci in Women of African Ancestry. International Journal of Cancer. PMID 31469419 DOI: 10.1002/Ijc.32653 |
0.356 |
|
| 2019 |
Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, ... ... Modugno F, et al. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31239549 DOI: 10.1038/S41379-019-0302-0 |
0.302 |
|
| 2019 |
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/Ije/Dyz113 |
0.515 |
|
| 2019 |
Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, ... ... Modugno F, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Medicine. PMID 31001917 DOI: 10.1002/Cam4.1996 |
0.382 |
|
| 2019 |
Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, ... ... Modugno F, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. PMID 30905014 DOI: 10.1007/S10552-019-01157-3 |
0.479 |
|
| 2019 |
Bast RC, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, ... ... Modugno F, et al. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Cancer. PMID 30835824 DOI: 10.1002/Cncr.32004 |
0.468 |
|
| 2019 |
Modugno F, Goughnour SL, Wallack D, Edwards RP, Odunsi K, Kelley JL, Moysich K, Ness RB, Brooks MM. Breastfeeding factors and risk of epithelial ovarian cancer. Gynecologic Oncology. PMID 30686553 DOI: 10.1016/J.Ygyno.2019.01.017 |
0.533 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Modugno F, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.502 |
|
| 2019 |
Cillo AR, Chuckran CA, Liao M, Modugno F, Edwards R, Coffman L, Vignali DAA, Bruno TC. Abstract TMIM-063: TARGETING NEUROPILIN-1+ T REGULATORY CELLS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER DECREASES TREG-SPECIFIC SUPPRESSION OF CD8+ T CELLS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-063 |
0.404 |
|
| 2019 |
Sasamoto N, Babic A, Jordan S, Risch H, Harris H, Rossing MA, Doherty J, Goodman M, Thompson P, Kjær SK, Jensen A, Schildkraut J, Titus L, Cramer D, Bandera E, ... ... Modugno F, et al. Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-640 |
0.55 |
|
| 2018 |
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, ... ... Modugno F, et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. PMID 30559148 DOI: 10.1158/0008-5472.Can-18-2726 |
0.376 |
|
| 2018 |
Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, ... ... Modugno F, et al. A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants. International Journal of Cancer. PMID 30499236 DOI: 10.1002/Ijc.32029 |
0.498 |
|
| 2018 |
Heng YJ, Wang J, Ahearn TU, Brown SB, Zhang X, Ambrosone CB, de Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, DuPre NC, Garcia-Closas M, Troester MA, et al. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Research and Treatment. PMID 30387004 DOI: 10.1007/S10549-018-5034-1 |
0.463 |
|
| 2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Modugno F, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.378 |
|
| 2018 |
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, ... ... Modugno F, et al. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research. PMID 30054336 DOI: 10.1158/0008-5472.Can-18-0951 |
0.42 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Modugno F, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.45 |
|
| 2018 |
Melnov S, Murphy P, Foley T, Nadyrov E, Kipen V, Leushev B, Modugno F. Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation. The Breast Journal. PMID 29785775 DOI: 10.1111/Tbj.13056 |
0.441 |
|
| 2018 |
Peres LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... ... Modugno F, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29584862 DOI: 10.1093/Ije/Dyy054 |
0.486 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Modugno F, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.533 |
|
| 2018 |
Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, ... ... Modugno F, et al. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clinic Proceedings. 93: 307-320. PMID 29502561 DOI: 10.1016/j.mayocp.2017.10.023 |
0.304 |
|
| 2018 |
Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes & Control : Ccc. PMID 29327114 DOI: 10.1007/S10552-017-0997-5 |
0.526 |
|
| 2018 |
Cillo AR, Bruno T, Modugno F, Edwards R, Vignali D. Abstract A23: Neuropilin-1 expression on regulatory T cells in ovarian cancer Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-A23 |
0.424 |
|
| 2018 |
Natanzon Y, Köbel M, Winham SJ, Armasu SM, McCauley BM, Vierkant RA, Cunningham JM, Bowtell D, Campbell IG, Chang-Claude J, deFazio A, Fasching PA, Goodman MT, Karlan BY, Modugno F, et al. Abstract 225: Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis Cancer Research. 78: 225-225. DOI: 10.1158/1538-7445.Am2018-225 |
0.363 |
|
| 2017 |
Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... ... Modugno F, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29211900 DOI: 10.1093/ije/dyx252 |
0.422 |
|
| 2017 |
Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.Epi-17-0655 |
0.548 |
|
| 2017 |
Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, ... ... Modugno F, et al. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. Jama Oncology. e173290. PMID 29049607 DOI: 10.1001/Jamaoncol.2017.3290 |
0.379 |
|
| 2017 |
Wang J, Heng YJ, Eliassen AH, Tamimi RM, Hazra A, Carey VJ, Ambrosone CB, de Andrade VP, Brufsky A, Couch FJ, King TA, Modugno F, Vachon CM, Hunter DJ, Beck AH, et al. Alcohol consumption and breast tumor gene expression. Breast Cancer Research : Bcr. 19: 108. PMID 28899409 DOI: 10.1186/S13058-017-0901-Y |
0.388 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, ... ... Modugno F, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1470-1473. PMID 28864456 DOI: 10.1158/1055-9965.Epi-17-0367 |
0.511 |
|
| 2017 |
Babic A, Harris HR, Vitonis AF, Titus LJ, Jordan SJ, Webb PM, Risch HA, Rossing MA, Doherty JA, Wicklund K, Goodman MT, Modugno F, Moysich KB, Ness R, et al. Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium. International Journal of Cancer. PMID 28833087 DOI: 10.1002/Ijc.31010 |
0.35 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, ... ... Modugno F, et al. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. British Journal of Cancer. PMID 28817835 DOI: 10.1038/Bjc.2017.267 |
0.477 |
|
| 2017 |
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/Bjc.2017.68 |
0.51 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer Causes & Control : Ccc. PMID 28293802 DOI: 10.1007/S10552-017-0867-1 |
0.492 |
|
| 2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... ... Modugno F, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.404 |
|
| 2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.344 |
|
| 2017 |
Bodelon C, Risch H, Modugno F, Webb P, Pearce CL, Pike M, Wentzensen N. Abstract A27: Timing of pregnancies and oral contraceptive use and risk of ovarian cancer Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-A27 |
0.537 |
|
| 2017 |
Harris HR, Jordan S, Risch H, Rossing MA, Goodman MT, Modugno F, Kjær SK, Schildkraut JM, Bandera EV, Wentzensen N, Phelan C, Anton-Culver H, Wu AH, Terry KL. Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium Cancer Research. 77: 2293-2293. DOI: 10.1158/1538-7445.Am2017-2293 |
0.563 |
|
| 2016 |
Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/Aje/Kww161 |
0.544 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Modugno F, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.372 |
|
| 2016 |
Cannioto RA, Sucheston-Campbell LE, Hampras S, Goode EL, Knutson K, Ness R, Modugno F, Wallace PK, Szender JB, Mayor P, Hong CC, Joseph JM, Friel G, Davis W, Nesline M, et al. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 27759594 DOI: 10.1097/Igc.0000000000000845 |
0.459 |
|
| 2016 |
Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, ... ... Modugno F, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 |
0.317 |
|
| 2016 |
Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, Wallace PK, ... ... Modugno F, et al. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27677730 DOI: 10.1158/1055-9965.Epi-16-0631 |
0.444 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Modugno F, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.372 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Modugno F, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.331 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.461 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Modugno F, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.436 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal of Cancer. PMID 27420401 DOI: 10.1002/Ijc.30274 |
0.516 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Modugno F, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.526 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Modugno F, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.534 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Modugno F, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.434 |
|
| 2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... ... Modugno F, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.417 |
|
| 2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.455 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Modugno F, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.375 |
|
| 2016 |
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Modugno F, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 |
0.395 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Modugno F, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.525 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Cancer Research. 76: 797-797. DOI: 10.1158/1538-7445.Am2016-797 |
0.484 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Modugno F, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.439 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Modugno F, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.352 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Modugno F, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.318 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Modugno F, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.332 |
|
| 2015 |
Liao S, Hartmaier RJ, McGuire KP, Puhalla SL, Luthra S, Chandran UR, Ma T, Bhargava R, Modugno F, Davidson NE, Benz S, Lee AV, Tseng GC, Oesterreich S. The molecular landscape of premenopausal breast cancer. Breast Cancer Research : Bcr. 17: 104. PMID 26251034 DOI: 10.1186/s13058-015-0618-8 |
0.348 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Modugno F, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.388 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Modugno F, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.351 |
|
| 2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Modugno F, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.492 |
|
| 2015 |
Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 26151456 DOI: 10.1038/Bjc.2015.245 |
0.521 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Modugno F, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.355 |
|
| 2015 |
Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB. Use of common analgesics is not associated with ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26063476 DOI: 10.1158/1055-9965.Epi-15-0508 |
0.549 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Modugno F, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.436 |
|
| 2015 |
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 671-6. PMID 25623732 DOI: 10.1158/1055-9965.Epi-14-1128 |
0.4 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Modugno F, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.35 |
|
| 2015 |
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Modugno F, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 |
0.334 |
|
| 2014 |
Kurta ML, Edwards RP, Moysich KB, McDonough K, Bertolet M, Weissfeld JL, Catov JM, Modugno F, Bunker CH, Ness RB, Diergaarde B. Prognosis and conditional disease-free survival among patients with ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4102-12. PMID 25403208 DOI: 10.1200/Jco.2014.55.1713 |
0.376 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Modugno F, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.524 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Modugno F, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.448 |
|
| 2014 |
Felix AS, Weissfeld JL, Pfeiffer RM, Modugno F, Black A, Hill LM, Martin J, Sit AS, Sherman ME, Brinton LA. Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial. International Journal of Cancer. Journal International Du Cancer. 134: 954-60. PMID 23907658 DOI: 10.1002/Ijc.28404 |
0.485 |
|
| 2014 |
Kurta M, Edwards R, Moysich K, McDonough K, Bertolet M, Weissfeld J, Catov J, Modugno F, Bunker C, Ness R, Diergaarde B. Abstract LB-273: Prognosis and conditional disease-free survival among ovarian cancer patients Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-273 |
0.408 |
|
| 2013 |
Köbel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, ... ... Modugno F, et al. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1677-86. PMID 23880734 DOI: 10.1158/1055-9965.Epi-13-0391 |
0.315 |
|
| 2013 |
Dallal C, Garte S, Ragin C, Chen J, Lloyd S, Modugno F, Weissfeld J, Taioli E. Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study. The International Journal of Biological Markers. 28: 161-7. PMID 23564622 DOI: 10.5301/Jbm.5000016 |
0.421 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Modugno F, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.428 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Modugno F, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.529 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Modugno F, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.397 |
|
| 2013 |
Hudson AG, Reeves KW, Modugno F, Wilson JW, Evans RW, Vogel VG, Gierach GL, Simpson J, Weissfeld JL. Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density. Nutrition and Cancer. 65: 410-6. PMID 23530640 DOI: 10.1080/01635581.2013.760744 |
0.584 |
|
| 2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Modugno F, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.476 |
|
| 2012 |
Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S. Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocrine-Related Cancer. 19: R255-79. PMID 23045324 DOI: 10.1530/ERC-12-0175 |
0.309 |
|
| 2012 |
Modugno F, Edwards RP. Ovarian cancer: Prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report International Journal of Gynecological Cancer. 22. PMID 23013733 DOI: 10.1097/IGC.0b013e31826bd1f2 |
0.314 |
|
| 2012 |
Mackey RH, Fanelli TJ, Modugno F, Cauley JA, McTigue KM, Brooks MM, Chlebowski RT, Manson JE, Klug TL, Kip KE, Curb JD, Kuller LH. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 2022-32. PMID 22933427 DOI: 10.1158/1055-9965.EPI-12-0759 |
0.397 |
|
| 2012 |
Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1282-92. PMID 22707710 DOI: 10.1158/1055-9965.Epi-12-0426 |
0.54 |
|
| 2011 |
Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Vuga M, Cauley JA. A method to estimate off-schedule observations in a longitudinal study. Annals of Epidemiology. 21: 297-303. PMID 21376277 DOI: 10.1016/J.Annepidem.2010.11.013 |
0.313 |
|
| 2011 |
Reeves KW, Weissfeld JL, Modugno F, Diergaarde B. Circulating levels of inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Research and Treatment. 127: 555-63. PMID 21069450 DOI: 10.1007/S10549-010-1249-5 |
0.376 |
|
| 2010 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Modugno F, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 |
0.448 |
|
| 2010 |
Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Lokshin AE. Development of a multimarker assay for early detection of ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2159-66. PMID 20368574 DOI: 10.1200/Jco.2008.19.2484 |
0.433 |
|
| 2009 |
Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Sternfeld B, Cauley JA. Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. International Journal of Cancer. Journal International Du Cancer. 124: 1169-77. PMID 19065651 DOI: 10.1002/Ijc.23996 |
0.399 |
|
| 2009 |
Reeves KW, Ness RB, Stone RA, Weissfeld JL, Vogel VG, Powers RW, Modugno F, Cauley JA. Vascular endothelial growth factor and breast cancer risk. Cancer Causes & Control : Ccc. 20: 375-86. PMID 18987982 DOI: 10.1007/S10552-008-9252-4 |
0.472 |
|
| 2008 |
Thomson CA, Neuhouser ML, Shikany JM, Caan BJ, Monk BJ, Mossavar-Rahmani Y, Sarto G, Parker LM, Modugno F, Anderson GL. The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative. Nutrition and Cancer. 60: 710-9. PMID 19005970 DOI: 10.1080/01635580802233983 |
0.505 |
|
| 2008 |
Kahlenborn C, Modugno F, Severs WB. Oral contraceptives and breast cancer. Mayo Clinic Proceedings. 83: 849-50; author reply. PMID 18614001 DOI: 10.4065/83.7.849-A |
0.46 |
|
| 2008 |
Oestreicher N, Capra A, Bromberger J, Butler LM, Crandall CJ, Gold EB, Greendale GA, Modugno F, Sternfeld B, Habel LA. Physical activity and mammographic density in a cohort of midlife women. Medicine and Science in Sports and Exercise. 40: 451-6. PMID 18379206 DOI: 10.1249/Mss.0B013E31815F5B47 |
0.413 |
|
| 2008 |
Hudson AG, Gierach GL, Modugno F, Simpson J, Wilson JW, Evans RW, Vogel VG, Weissfeld JL. Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 680-7. PMID 18349287 DOI: 10.1158/1055-9965.Epi-07-2739 |
0.63 |
|
| 2008 |
McTiernan A, Wu L, Barnabei VM, Chen C, Hendrix S, Modugno F, Rohan T, Stanczyk FZ, Wang CY. Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Research and Treatment. 108: 217-31. PMID 18297397 DOI: 10.1007/S10549-007-9588-6 |
0.368 |
|
| 2008 |
Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, ... ... Modugno F, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British Journal of Cancer. 98: 282-8. PMID 18219286 DOI: 10.1038/Sj.Bjc.6604170 |
0.571 |
|
| 2008 |
Butler LM, Gold EB, Greendale GA, Crandall CJ, Modugno F, Oestreicher N, Quesenberry CP, Habel LA. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Research and Treatment. 112: 165-74. PMID 18066689 DOI: 10.1007/S10549-007-9840-0 |
0.46 |
|
| 2007 |
Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA. Body mass index and mortality among older breast cancer survivors in the study of osteoporotic fractures Cancer Epidemiology Biomarkers and Prevention. 16: 1468-1473. PMID 17627012 DOI: 10.1158/1055-9965.Epi-07-0051 |
0.478 |
|
| 2007 |
Reeves KW, Gierach GL, Modugno F. Recreational physical activity and mammographic breast density characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 934-42. PMID 17507619 DOI: 10.1158/1055-9965.Epi-06-0732 |
0.606 |
|
| 2007 |
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Modugno F, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 |
0.327 |
|
| 2007 |
Wang J, Higuchi R, Modugno F, Li J, Umblas N, Lee J, Lui LY, Ziv E, Tice JA, Cummings SR, Rhees B. Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Breast Cancer Research and Treatment. 106: 273-80. PMID 17268813 DOI: 10.1007/S10549-007-9497-8 |
0.483 |
|
| 2006 |
Kahlenborn C, Modugno F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clinic Proceedings. 81: 1290-302. PMID 17036554 DOI: 10.4065/81.10.1290 |
0.516 |
|
| 2006 |
McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring, Md.). 14: 1662-77. PMID 17030978 DOI: 10.1038/Oby.2006.191 |
0.439 |
|
| 2006 |
Zmuda JM, Modugno F, Weissfeld JL, Cauley JA, Trump DL, Moffett SP, Ferrell RE. Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction. Oncology. 70: 185-9. PMID 16763406 DOI: 10.1159/000093805 |
0.414 |
|
| 2006 |
Greer JB, Modugno F, Ness RB, Allen GO. Anthropometry and the risk of epithelial ovarian cancer Cancer. 106: 2247-2257. PMID 16596653 DOI: 10.1002/Cncr.21830 |
0.518 |
|
| 2006 |
Ness RB, Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers European Journal of Cancer. 42: 691-703. PMID 16531042 DOI: 10.1016/J.Ejca.2006.01.009 |
0.545 |
|
| 2006 |
Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM, Gorelik E. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecologic Oncology. 102: 244-51. PMID 16434085 DOI: 10.1016/J.Ygyno.2005.12.011 |
0.396 |
|
| 2006 |
Gierach GL, Modugno F, Ness RB. Gender of offspring and maternal ovarian cancer risk Gynecologic Oncology. 101: 476-480. PMID 16364411 DOI: 10.1016/J.Ygyno.2005.11.008 |
0.698 |
|
| 2006 |
Modugno F, Ngo DL, Allen GO, Kuller LH, Ness RB, Vogel VG, Costantino JP, Cauley JA. Breast cancer risk factors and mammographic breast density in women over age 70 Breast Cancer Research and Treatment. 97: 157-166. PMID 16362132 DOI: 10.1007/S10549-005-9105-8 |
0.43 |
|
| 2006 |
Modugno F, Kip KE, Cochrane B, Kuller L, Klug TL, Rohan TE, Chlebowski RT, Lasser N, Stefanick ML. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer. International Journal of Cancer. 118: 1292-301. PMID 16161054 DOI: 10.1002/Ijc.21487 |
0.443 |
|
| 2005 |
Sun M, Sun M, Lyons-Weiler J, Lokshin AE, Modugno F, Marks J, Bigbee WL. Serum proteomic profiling distinguishes estrogen receptor (ER) positive and ER negative breast cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 578. PMID 27946485 DOI: 10.1200/Jco.2005.23.16_Suppl.578 |
0.419 |
|
| 2005 |
Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: A hypothesis Cancer Epidemiology Biomarkers and Prevention. 14: 2840-2847. PMID 16364998 DOI: 10.1158/1055-9965.Epi-05-0493 |
0.402 |
|
| 2005 |
Davies B, Chen J, Modugno F, Weissfeld J, Landsittel D, Dhir R, Nelson J, Getzenberg RH. Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancer. The Journal of Urology. 174: 1767-70. PMID 16217280 DOI: 10.1097/01.Ju.0000177070.13987.Ce |
0.301 |
|
| 2005 |
Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings SR, Stone KL, Morin PA, Greene D, Cauley JA. Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Breast Cancer Research and Treatment. 93: 261-70. PMID 16142442 DOI: 10.1007/S10549-005-5347-8 |
0.515 |
|
| 2005 |
Greer JB, Modugno F, Allen GO, Ness RB. Short-term oral contraceptive use and the risk of epithelial ovarian cancer American Journal of Epidemiology. 162: 66-72. PMID 15961588 DOI: 10.1093/Aje/Kwi162 |
0.544 |
|
| 2005 |
Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings SR, Stone KL, Morin PA, Greene D, Cauley JA. Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women. International Journal of Cancer. Journal International Du Cancer. 116: 984-91. PMID 15856463 DOI: 10.1002/Ijc.21105 |
0.487 |
|
| 2005 |
Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB, Lokshin AE. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 981-7. PMID 15824174 DOI: 10.1158/1055-9965.Epi-04-0404 |
0.399 |
|
| 2005 |
Greer JB, Modugno F, Allen GO, Ness RB. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer Obstetrics and Gynecology. 105: 731-740. PMID 15802398 DOI: 10.1097/01.Aog.0000154152.12088.48 |
0.541 |
|
| 2005 |
Gierach GL, Modugno F, Ness RB. Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk American Journal of Epidemiology. 161: 452-461. PMID 15718481 DOI: 10.1093/aje/kwi069 |
0.622 |
|
| 2004 |
Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. American Journal of Obstetrics and Gynecology. 191: 733-40. PMID 15467532 DOI: 10.1016/J.Ajog.2004.03.035 |
0.452 |
|
| 2004 |
Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH. Analysis of CHEK2 gene for ovarian cancer susceptibility. Gynecologic Oncology. 95: 62-9. PMID 15385111 DOI: 10.1016/J.Ygyno.2004.07.015 |
0.539 |
|
| 2004 |
Modugno F. Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review. American Journal of Epidemiology. 159: 319-35. PMID 14769635 DOI: 10.1093/Aje/Kwh046 |
0.522 |
|
| 2004 |
Modugno F. Erratum to “Ovarian cancer and high-risk women—implications for prevention, screening, and early detection” [Gynecol. Oncol. 91 (2003) 15–31] Gynecologic Oncology. 92: 731. DOI: 10.1016/J.Ygyno.2003.10.041 |
0.427 |
|
| 2003 |
Modugno F, Ness RB, Allen GO. Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer Obstetrics and Gynecology. 102: 1336-1343. PMID 14662224 DOI: 10.1016/J.Obstetgynecol.2003.08.008 |
0.428 |
|
| 2003 |
Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and Its Treatment with Danazol or Lupron in Relation to Ovarian Cancer Clinical Cancer Research. 9: 5142-5144. PMID 14613992 |
0.482 |
|
| 2003 |
Modugno F, Boyd J, Baum A, Bigbee WL, Cramer D, Ferrell R, Gallion HH, Greene MH, Goldman P, Johnson KA, Junker B, Kuller L, Kurman RJ, Maihle N, Narod S, et al. Ovarian cancer and high-risk women - Implications for prevention, screening, and early detection Gynecologic Oncology. 91: 15-31. PMID 14529658 DOI: 10.1016/S0090-8258(03)00254-3 |
0.474 |
|
| 2003 |
Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S, Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer DW, Dube MP, Narod SA. Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States). Cancer Causes & Control : Ccc. 14: 439-46. PMID 12946038 DOI: 10.1023/A:1024932427503 |
0.364 |
|
| 2002 |
Sit ASY, Modugno F, Weissfeld JL, Berga SL, Ness RB. Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma Gynecologic Oncology. 86: 118-123. PMID 12144815 DOI: 10.1006/Gyno.2002.6746 |
0.459 |
|
| 2002 |
Modugno F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer Epidemiology. 13: 467-471. PMID 12094103 DOI: 10.1097/00001648-200207000-00016 |
0.366 |
|
| 2001 |
Modugno F, Ness RB, Wheeler JE. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness Annals of Epidemiology. 11: 568-574. PMID 11709277 DOI: 10.1016/S1047-2797(01)00213-7 |
0.537 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Liu G, Lee S, Lee AW, Wu AH, Bandera EV, Jensen A, Anne Rossing M, Moysich KB, Chang-Claude J, Doherty J, Gentry-Maharaj A, Kiemeney L, Gayther SA, Modugno F, Massuger L, et al. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. American Journal of Epidemiology. PMID 28633381 DOI: 10.1093/Aje/Kwx243 |
0.297 |
|
| 2007 |
Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. Journal of Dental Research. 86: 104-14. PMID 17251508 DOI: 10.1177/154405910708600202 |
0.294 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Modugno F, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.29 |
|
| 2003 |
Modugno F, Ness RB, Ewing S, Cauley JA. Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis. Obstetrics and Gynecology. 101: 353-61. PMID 12576261 DOI: 10.1016/S0029-7844(02)02589-9 |
0.267 |
|
| 2009 |
Ragin CC, Dallal C, Okobia M, Modugno F, Chen J, Garte S, Taioli E. Leptin levels and leptin receptor polymorphism frequency in healthy populations. Infectious Agents and Cancer. 4: S13. PMID 19208204 DOI: 10.1186/1750-9378-4-S1-S13 |
0.266 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Modugno F, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.26 |
|
| 2018 |
Theodoraki MN, Yerneni S, Sarkar SN, Orr B, Muthuswamy R, Voyten J, Modugno F, Jiang W, Grimm M, Basse PH, Bartlett DL, Edwards R, Kalinski P. Helicase-driven activation of NFκB-COX2 mediates the immunosuppressive component of dsRNA-driven inflammation in the human tumor microenvironment. Cancer Research. PMID 29853604 DOI: 10.1158/0008-5472.Can-17-3985 |
0.257 |
|
| 2021 |
Chuckran CA, Cillo AR, Moskovitz J, Overacre-Delgoffe A, Somasundaram AS, Shan F, Magnon GC, Kunning SR, Abecassis I, Zureikat AH, Luketich J, Pennathur A, Sembrat J, Rojas M, Merrick DT, ... ... Modugno F, et al. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer. Science Translational Medicine. 13: eabf8495. PMID 34878821 DOI: 10.1126/scitranslmed.abf8495 |
0.257 |
|
| 2004 |
Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL. Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1459-65. PMID 15342446 |
0.255 |
|
| 2016 |
Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, et al. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and Gynecology. PMID 27054934 DOI: 10.1097/01.Ogx.0000489579.62561.B8 |
0.255 |
|
| 2000 |
Modugno F, Weissfeld JL, Hill LM. Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound. Gynecologic Oncology. 77: 289-92. PMID 10785480 DOI: 10.1006/Gyno.2000.5785 |
0.248 |
|
| 2023 |
Cole AJ, Panesso-Gomez S, Shah JS, Ebai T, Jiang Q, Gumusoglu-Acar E, Bello MG, Vlad A, Modugno F, Edwards RP, Buckanovich RJ. Quiescent ovarian cancer cells secrete follistatin to induce chemotherapy resistance in surrounding cells in response to chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36795892 DOI: 10.1158/1078-0432.CCR-22-2254 |
0.237 |
|
| 2006 |
Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. British Journal of Cancer. 95: 1432-8. PMID 17003776 DOI: 10.1038/Sj.Bjc.6603394 |
0.232 |
|
| 2023 |
Saner FAM, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, Fereday S, Twomey L, Pishas KI, Hoang T, Bolithon A, Traficante N, Alsop K, Christie EL, ... ... Modugno F, et al. Concurrent RB1 loss and -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma. Medrxiv : the Preprint Server For Health Sciences. PMID 37986741 DOI: 10.1101/2023.11.09.23298321 |
0.229 |
|
| 2023 |
Köbel M, Kang EY, Weir A, Rambau PF, Lee CH, Nelson GS, Ghatage P, Meagher NS, Riggan MJ, Alsop J, Anglesio MS, Beckmann MW, Bisinotto C, Boisen M, Boros J, ... ... Modugno F, et al. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. The Journal of Pathology. Clinical Research. PMID 36948887 DOI: 10.1002/cjp2.311 |
0.222 |
|
| 2006 |
Oestreicher N, Habel LA, Crandall C, Greendale GA, Modugno F, Sternfeld B, Gold EB. Association of Active Smoking and Environmental Tobacco Smoke (ETS) with Mammographic Density in a Pre/Perimenopausal Cohort American Journal of Epidemiology. 163: S254-S254. DOI: 10.1093/Aje/163.Suppl_11.S254-A |
0.219 |
|
| 2021 |
Cunningham JM, Winham SJ, Wang C, Weigelt B, Fu Z, Armasu SM, McCauley BM, Brand AH, Chiew YE, Elishaev E, Gourley C, Kennedy CJ, Laslvic A, Lester J, Piskorz A, ... ... Modugno F, et al. DNA Methylation Profiles of Ovarian Clear Cell Carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34697060 DOI: 10.1158/1055-9965.EPI-21-0677 |
0.217 |
|
| 2004 |
Szema AM, Khedkar M, Maloney P, Mickels MS, Patel H, Modugno F, Tso A, Lin D. Clinical deterioration in pediatric asthma patients living near the world trade center after 9/11/01 The Journal of Allergy and Clinical Immunology. 113. DOI: 10.1016/J.Jaci.2004.01.581 |
0.214 |
|
| 2021 |
Heinze K, Nazeran TM, Lee S, Krämer P, Cairns ES, Chiu DS, Leung SCY, Kang EY, Meagher NS, Kennedy CJ, Boros J, Kommoss F, Vollert HW, Heitze F, du Bois A, ... ... Modugno F, et al. Validated biomarker assays confirm ARID1A loss is confounded with MMR deficiency, CD8 TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. The Journal of Pathology. PMID 34897700 DOI: 10.1002/path.5849 |
0.213 |
|
| 2004 |
Szema AM, Khedkar M, Maloney PF, Takach PA, Nickels MS, Patel H, Modugno F, Tso AY, Lin DH. Clinical deterioration in pediatric asthmatic patients after September 11, 2001. The Journal of Allergy and Clinical Immunology. 113: 420-6. PMID 15007340 DOI: 10.1016/J.Jaci.2003.12.015 |
0.212 |
|
| 2022 |
Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, Riggan MJ, Bolithon A, Popovic G, Leung B, Tang K, Lambie N, Millstein J, Alsop J, ... ... Modugno F, et al. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Cancer. PMID 36572991 DOI: 10.1002/cncr.34582 |
0.202 |
|
| 2017 |
Theodoraki M, Muthuswamy R, Voyten J, Modugno F, Obermajer N, Edwards RP, Kalinski P. Abstract 951: Induction of COX-2 and NFκB activation represent TLR3-independent undesirable aspects of poly-I:C activity Cancer Research. 77: 951-951. DOI: 10.1158/1538-7445.Am2017-951 |
0.198 |
|
| 2021 |
Kang EY, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Da-Anoy A, Lambrechts D, Loverix L, ... ... Modugno F, et al. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv : An International Journal of Pathology. PMID 34782936 DOI: 10.1007/s00428-021-03232-0 |
0.197 |
|
| 2017 |
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC, Lee JM, Coetzee S, Beesley J, ... ... Modugno F, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics. PMID 28346442 DOI: 10.1038/ng.3826 |
0.196 |
|
| 2018 |
Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, Gentry-Maharaj A, Menon U, Hernando Polo S, Candido Dos Reis FJ, Doherty JA, ... ... Modugno F, et al. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. The Journal of Pathology. Clinical Research. PMID 30062862 DOI: 10.1002/cjp2.109 |
0.187 |
|
| 2022 |
Meagher NS, Gorringe KL, Wakefield MJ, Bolithon A, Pang CNI, Chiu DS, Anglesio MS, Mallitt KA, Doherty JA, Harris HR, Schildkraut JM, Berchuck A, Cushing-Haugen KL, Chezar K, Chou A, ... ... Modugno F, et al. Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36222710 DOI: 10.1158/1078-0432.CCR-22-1206 |
0.187 |
|
| 2003 |
Modugno F, Knoll C, Kanbour-Shakir A, Romkes M. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Research and Treatment. 82: 191-7. PMID 14703066 DOI: 10.1023/B:Brea.0000004376.21491.44 |
0.183 |
|
| 2022 |
Weir A, Kang EY, Meagher NS, Nelson GS, Ghatage P, Lee CH, Riggan MJ, Gentry-Maharaj A, Ryan A, Singh N, Widschwendter M, Alsop J, Anglesio MS, Beckmann MW, Berger J, ... ... Modugno F, et al. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British Journal of Cancer. PMID 36323878 DOI: 10.1038/s41416-022-02014-y |
0.182 |
|
| 2014 |
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Modugno F, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 |
0.181 |
|
| 2007 |
Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M, Quesenberry C, Sternfeld B. Mammographic density in a multiethnic cohort. Menopause (New York, N.Y.). 14: 891-9. PMID 17414171 DOI: 10.1097/Gme.0B013E318032569C |
0.167 |
|
| 2022 |
Atiya HI, Frisbie L, Goldfeld E, Orellana T, Donellan N, Modugno F, Calderon M, Watkins SC, Zhang R, Elishaev E, Soong TR, Vlad AM, Coffman LG. Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation. Cancer Research. PMID 36219681 DOI: 10.1158/0008-5472.CAN-22-1294 |
0.131 |
|
| 2022 |
Bolton KL, Chen D, Corona de la Fuente RI, Fu Z, Murali R, K Bel M, Tazi Y, Cunningham JM, Chan ICC, Wiley BJ, Moukarzel LA, Winham SJ, Armasu SM, Lester J, Elishaev E, ... ... Modugno F, et al. Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35816189 DOI: 10.1158/1078-0432.CCR-21-3817 |
0.122 |
|
| Hide low-probability matches. |